×
Log in
Upload File
Most Popular
Art & Photos
Automotive
Business
Career
Design
Education
Hi-Tech
+ Browse for More
proactive-capital-resources-group documents
Investor Relations
Bioheart (OTC: BHRT; Twitter: $BHRT)
Health & Medicine
LifeTech Capital Updates NeoStem (NBS) Strong Buy $4.00 Target
Investor Relations
The ProActive Network's PRISM product
Business
FDA Phase III Approval Historical Stock Performance
Health & Medicine
DARA Bio ($DARA) - KRN5500 article from the Journal of Pain and Symptom Management International
Economy & Finance
Lazard Capital Markets Research Report on Ventrus Biosciences (NASDAQ: VTUS; Stock Twits; $VTUS)
Business
Leerink Swann Research Report on Ventrus Bio ($VTUS)
Health & Medicine
UniLife Corporation (NASDAQ: UNIS) @ Cowan
Investor Relations
Unilife ($UNIS) - Jefferies Healthcare Conference
Investor Relations
Unilife ($UNIS) Investor Presentation - July 2011
Investor Relations
Medgenics (NYSE AMEX: MDGN) - Nomura Code Securities Limited, London
Business
Griffin Securities reiterates Unilife Corp ($UNIS) target with $10.50 target
Investor Relations
Tonix Presentation November 2011
Investor Relations
Unilife ($UNIS) - Prefilled Syringes Issue of OnDrugDelivery
Investor Relations
Unilife Corp ($UNIS) - Innovative Drug Delivery Device Solutions
Investor Relations
Misonix (NASDAQ: MSON) Technology and Growth Status Report - May 2011
Technology
Vringo Presentation
Investor Relations
Rodman & Renshaw - $VTUS May 2011 Update
Investor Relations
Medgenics (NYSE AMEX: MDGN) - Maxim Group Research Report
Investor Relations
Ensurge, Inc. (OTCBB: ESGI; Twitter: $ESGI)
Investor Relations
Ventrus Bio Investor Presentation - May 2011
Next >